4.27
price down icon0.70%   -0.03
pre-market  Pre-market:  4.28   0.01   +0.23%
loading

Humacyte Inc Stock (HUMA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
1.51%
26.58
26.18 24.62 26.73 22.51
Interest Income/Expense
5.15%
1.816
1.727 1.463 1.71 1.699
Operating Income/Loss
1.51%
-26.58
-26.18 -24.62 -26.73 -22.51
Nonoperating Income/Loss
594.24%
-5.318
1.076 -1.373 4.025 -14.46
Income/Loss From Continuing Operations Before Tax
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Net Income/Loss
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
171.31K%
108.25
0.0632 103.44 103.36 103.26
Diluted Average Shares
171.31K%
108.25
0.0632 103.44 103.36 103.26
Basic Earnings Per Share
20.83%
-0.29
-0.24 -0.25 -0.22 -0.36
Diluted Earnings Per Share
20.83%
-0.29
-0.24 -0.25 -0.22 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):